PL1718336T3 - Nowe połączenie środków antycholinergicznych i beta-mimetyków do leczenia chorób układu oddechowego - Google Patents
Nowe połączenie środków antycholinergicznych i beta-mimetyków do leczenia chorób układu oddechowegoInfo
- Publication number
- PL1718336T3 PL1718336T3 PL05701139T PL05701139T PL1718336T3 PL 1718336 T3 PL1718336 T3 PL 1718336T3 PL 05701139 T PL05701139 T PL 05701139T PL 05701139 T PL05701139 T PL 05701139T PL 1718336 T3 PL1718336 T3 PL 1718336T3
- Authority
- PL
- Poland
- Prior art keywords
- anticholinergic
- treatment
- respiratory diseases
- novel combination
- beta mimetics
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/401—Proline; Derivatives thereof, e.g. captopril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Otolaryngology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54195704P | 2004-02-06 | 2004-02-06 | |
| PCT/EP2005/000649 WO2005074900A2 (en) | 2004-02-06 | 2005-01-24 | NOVEL COMBINATION OF ANTICHOLINERGIC AND β MIMETICS FOR THE TREATMENT OF RESPIRATORY DISEASES |
| EP05701139A EP1718336B1 (en) | 2004-02-06 | 2005-01-24 | Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1718336T3 true PL1718336T3 (pl) | 2008-11-28 |
Family
ID=34837534
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL05701139T PL1718336T3 (pl) | 2004-02-06 | 2005-01-24 | Nowe połączenie środków antycholinergicznych i beta-mimetyków do leczenia chorób układu oddechowego |
Country Status (19)
| Country | Link |
|---|---|
| US (3) | US20050175549A1 (pl) |
| EP (1) | EP1718336B1 (pl) |
| JP (1) | JP5524442B2 (pl) |
| CN (1) | CN1905902A (pl) |
| AT (1) | ATE399027T1 (pl) |
| AU (1) | AU2005210083B2 (pl) |
| CA (1) | CA2550841C (pl) |
| CY (1) | CY1108326T1 (pl) |
| DE (1) | DE602005007708D1 (pl) |
| DK (1) | DK1718336T3 (pl) |
| ES (1) | ES2309705T3 (pl) |
| HR (1) | HRP20080439T3 (pl) |
| NO (1) | NO337128B1 (pl) |
| NZ (1) | NZ548302A (pl) |
| PL (1) | PL1718336T3 (pl) |
| PT (1) | PT1718336E (pl) |
| RU (1) | RU2438660C2 (pl) |
| SI (1) | SI1718336T1 (pl) |
| WO (1) | WO2005074900A2 (pl) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2165768B1 (es) | 1999-07-14 | 2003-04-01 | Almirall Prodesfarma Sa | Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen. |
| JP4819699B2 (ja) * | 2004-02-06 | 2011-11-24 | メダ ファーマ ゲゼルシャフト ミット ベシュレンクテル ハフツング ウント コンパニー コマンディト ゲゼルシャフト | 喘息及びｃｏｐｄの長期間の治療のための抗コリン作用薬及びグルココルチコイドの組合せ剤 |
| GB0410398D0 (en) * | 2004-05-10 | 2004-06-16 | Arakis Ltd | The treatment of respiratory disease |
| ES2257152B1 (es) * | 2004-05-31 | 2007-07-01 | Laboratorios Almirall S.A. | Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos. |
| CA2632780C (en) * | 2005-12-21 | 2013-11-12 | Meda Pharma Gmbh & Co. Kg | Combination of r,r-glycopyrrolate, rolipram, and budesonide for the treatment of inflammatory diseases |
| US20080031828A1 (en) * | 2006-08-03 | 2008-02-07 | Boehringer Ingelheim International Gmbh | Method for the Treatment of Dyspnea Comprising Combined Administration of Tiotropium Salts and Salts of Salmeterol |
| EP1944018A1 (en) * | 2007-01-10 | 2008-07-16 | CHIESI FARMACEUTICI S.p.A. | Micronised particles of low-dosage strength active agents for powder formulations for inhalation |
| GB0801876D0 (en) | 2008-02-01 | 2008-03-12 | Vectura Group Plc | Suspension formulations |
| AU2009241628A1 (en) * | 2008-02-26 | 2009-11-05 | Elevation Pharmaceuticals, Inc. | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| US20100055045A1 (en) | 2008-02-26 | 2010-03-04 | William Gerhart | Method and system for the treatment of chronic obstructive pulmonary disease with nebulized anticholinergic administrations |
| EP2100598A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2100599A1 (en) | 2008-03-13 | 2009-09-16 | Laboratorios Almirall, S.A. | Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease |
| EP2221048A1 (en) | 2009-02-18 | 2010-08-25 | Siegfried Generics International AG | Pharmaceutical composition for inhalation |
| US8815258B2 (en) | 2009-05-29 | 2014-08-26 | Pearl Therapeutics, Inc. | Compositions, methods and systems for respiratory delivery of two or more active agents |
| AU2010253776B2 (en) * | 2009-05-29 | 2015-01-22 | Pearl Therapeutics, Inc. | Compositions for pulmonary delivery of long-acting muscarinic antagonists and long-acting B2 adrenergic receptor agonists and associated methods and systems |
| US20110132355A1 (en) * | 2009-06-09 | 2011-06-09 | William Gerhart | Treatment of chronic obstructive pulmonary disease with nebulized beta 2-agonist or combined nebulized beta 2-agonist and anticholinergic administration |
| DK2515855T6 (da) * | 2009-12-23 | 2023-06-06 | Chiesi Farm Spa | Kombinationsterapi til COPD |
| KR20120106753A (ko) * | 2009-12-23 | 2012-09-26 | 키에시 파르마슈티시 엣스. 피. 에이. | Ｃｏｐｄ용 에어로졸 제제 |
| DK2515854T3 (da) | 2009-12-23 | 2014-05-26 | Chiesi Farma Spa | Aerosolformulering for COPD |
| KR101738712B1 (ko) * | 2009-12-23 | 2017-05-22 | 키에시 파르마슈티시 엣스. 피. 에이. | Ｃｏｐｄ용 조합요법 |
| EP2749277A3 (en) | 2011-02-17 | 2014-08-27 | Cipla Limited | Combination of glycopyrronium and vilanterol |
| JO3510B1 (ar) | 2011-03-04 | 2020-07-05 | Heptares Therapeutics Ltd | استخدام جلايكوبيرولات لعلاج عدم انتظام دقات القلب |
| EP2510928A1 (en) | 2011-04-15 | 2012-10-17 | Almirall, S.A. | Aclidinium for use in improving the quality of sleep in respiratory patients |
| SG194896A1 (en) * | 2011-05-17 | 2013-12-30 | Pearl Therapeutics Inc | Compositions, methods & systems for respiratory delivery of two or more active agents |
| WO2014144894A1 (en) | 2013-03-15 | 2014-09-18 | Pearl Therapeutics, Inc. | Methods and systems for conditioning of particulate crystalline materials |
| ES2666905T4 (es) * | 2013-12-30 | 2018-06-07 | Chiesi Farmaceutici S.P.A. | Composición en solución para aerosol estable presurizada de una combinación de bromuro de glicopirronio y formoterol |
| TN2016000261A1 (en) | 2013-12-30 | 2017-10-06 | Chiesi Farm Spa | Stable pressurised aerosol solution composition of glycopyrronium bromide and formoterol combination. |
| WO2017077488A1 (en) * | 2015-11-04 | 2017-05-11 | Glenmark Pharmaceuticals Limited | An inhalable fixed dose powder composition comprising glycopyrronium and formoterol |
| US20220395454A1 (en) | 2019-12-02 | 2022-12-15 | Chiesi Farmaceutici S.P.A. | Stainless steel can for pressurised metered dose inhalers |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0937041T3 (da) | 1996-11-11 | 2003-08-11 | Christian R Noe | Anvendelse af et farmaceutisk egnet salt af (3R,2'R)-3-[(cyclopentil-hydroxyphenylacetyl)oxyl]-1,1-dimethyl-pyrrolidinium til fremstilling af et lægemiddel |
| WO2000006121A1 (de) | 1998-07-24 | 2000-02-10 | Jago Research Ag | Medizinische aerosolformulierungen |
| WO2000007567A1 (de) * | 1998-08-04 | 2000-02-17 | Jago Research Ag | Medizinische aerosolformulierungen |
| CZ303154B6 (cs) * | 1998-11-13 | 2012-05-09 | Jagotec Ag | Suchá prášková formulace k inhalaci obsahující stearát horecnatý |
| DE19921693A1 (de) * | 1999-05-12 | 2000-11-16 | Boehringer Ingelheim Pharma | Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika |
| US20040002548A1 (en) * | 1999-05-12 | 2004-01-01 | Boehringer Ingelheim Pharma Kg | Medicament compositions containing anticholinergically-effective compounds and betamimetics |
| DE19961300A1 (de) * | 1999-12-18 | 2001-06-21 | Asta Medica Ag | Vorratssystem für Arzneimittel in Pulverform und damit ausgestatteter Inhalator |
| GB0008660D0 (en) * | 2000-04-07 | 2000-05-31 | Arakis Ltd | The treatment of respiratory diseases |
| RU2294737C2 (ru) * | 2001-03-30 | 2007-03-10 | Яготек Аг | Медицинские аэрозольные составы |
| US6667344B2 (en) * | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
-
2005
- 2005-01-24 SI SI200530323T patent/SI1718336T1/sl unknown
- 2005-01-24 NZ NZ548302A patent/NZ548302A/en unknown
- 2005-01-24 PL PL05701139T patent/PL1718336T3/pl unknown
- 2005-01-24 RU RU2006132036/15A patent/RU2438660C2/ru not_active Application Discontinuation
- 2005-01-24 PT PT05701139T patent/PT1718336E/pt unknown
- 2005-01-24 EP EP05701139A patent/EP1718336B1/en active Active
- 2005-01-24 DK DK05701139T patent/DK1718336T3/da active
- 2005-01-24 JP JP2006551761A patent/JP5524442B2/ja not_active Expired - Fee Related
- 2005-01-24 DE DE602005007708T patent/DE602005007708D1/de active Active
- 2005-01-24 WO PCT/EP2005/000649 patent/WO2005074900A2/en active IP Right Grant
- 2005-01-24 CN CNA2005800019327A patent/CN1905902A/zh active Pending
- 2005-01-24 AU AU2005210083A patent/AU2005210083B2/en not_active Ceased
- 2005-01-24 CA CA2550841A patent/CA2550841C/en not_active Expired - Fee Related
- 2005-01-24 AT AT05701139T patent/ATE399027T1/de active
- 2005-01-24 ES ES05701139T patent/ES2309705T3/es active Active
- 2005-02-07 US US11/051,469 patent/US20050175549A1/en not_active Abandoned
-
2006
- 2006-07-11 US US11/483,693 patent/US20060252815A1/en not_active Abandoned
- 2006-08-31 NO NO20063882A patent/NO337128B1/no not_active IP Right Cessation
-
2007
- 2007-07-30 US US11/882,109 patent/US7985766B2/en active Active
-
2008
- 2008-09-10 HR HR20080439T patent/HRP20080439T3/xx unknown
- 2008-09-10 CY CY20081100967T patent/CY1108326T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2309705T3 (es) | 2008-12-16 |
| RU2438660C2 (ru) | 2012-01-10 |
| AU2005210083B2 (en) | 2010-03-11 |
| AU2005210083A1 (en) | 2005-08-18 |
| EP1718336B1 (en) | 2008-06-25 |
| WO2005074900A2 (en) | 2005-08-18 |
| PT1718336E (pt) | 2008-08-28 |
| NO337128B1 (no) | 2016-01-25 |
| CN1905902A (zh) | 2007-01-31 |
| JP2007520506A (ja) | 2007-07-26 |
| HRP20080439T3 (en) | 2008-10-31 |
| SI1718336T1 (sl) | 2008-10-31 |
| CA2550841A1 (en) | 2005-08-18 |
| JP5524442B2 (ja) | 2014-06-18 |
| CA2550841C (en) | 2012-10-02 |
| ATE399027T1 (de) | 2008-07-15 |
| DE602005007708D1 (de) | 2008-08-07 |
| WO2005074900A3 (en) | 2006-04-06 |
| DK1718336T3 (da) | 2008-10-20 |
| US20070270481A1 (en) | 2007-11-22 |
| NZ548302A (en) | 2010-04-30 |
| US20050175549A1 (en) | 2005-08-11 |
| EP1718336A2 (en) | 2006-11-08 |
| US20060252815A1 (en) | 2006-11-09 |
| US7985766B2 (en) | 2011-07-26 |
| RU2006132036A (ru) | 2008-03-20 |
| NO20063882L (no) | 2006-10-26 |
| CY1108326T1 (el) | 2014-02-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SI1718336T1 (sl) | Nova kombinacija antiholinergika in beta mimetikov za zdravljenje respiratornih bolezni | |
| EP2206512A3 (en) | Increase of interferon-beta for anti-virus therapy for respiratory diseases | |
| TW200708513A (en) | Novel crystalline forms of tiotropium bromide | |
| WO2006117300A3 (en) | Crystalline forms of tiotropium bromide | |
| WO2008149149A3 (en) | Polypeptides, antibody variable domains and antagonists | |
| MY146628A (en) | Novel crystalline anhydride with anticholinergic effect | |
| MXPA02011311A (es) | Composicion novedosa. | |
| WO2008149144A3 (en) | Polypeptides, antibody variable domains and antagonists | |
| HK1114013A1 (en) | The combination of anticholinergics and leukotriene receptor antagonists for the treatment of repiratory diseases | |
| NO20070651L (no) | Sammensetninger av statiner med bronkodilatorer | |
| UA83813C2 (ru) | Порошковое лекарственное средство, которое содержит соль тиотропия и ксинафоат салметерола | |
| WO2005086915A3 (en) | Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor | |
| WO2003020313A1 (fr) | Medicaments contre les maladies respiratoires renfermant un agent de regulation du recepteur de la sphingosine-1-phosphate | |
| AU2001252192A1 (en) | Agent for treating illnesses of the tracheobronchial tract, especially chronic obstructive pulmonary disease (copd) | |
| IL199022A0 (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma | |
| MXPA03011702A (es) | Composicion que comprende un inhibidor de fosodiesterasa 4 y un antagonista de receptor h1 y el uso de los mismos para la elaboracion de un medicamento para el tratamiento de enfermedades respiratorias. | |
| SG149876A1 (en) | Novel tiotropium salts, methods for the production thereof, and pharmaceutical formulations containing the same | |
| SE9900834D0 (sv) | Novel combination | |
| IL189182A0 (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (copd) and asthma | |
| MXPA04007294A (es) | Composicion para inhalacion. | |
| EP1651170A4 (en) | COMBINATION OF DEHYDROEPIANDROSTERONE OR DEHYDROEPIANDROSTERONE SULFATE WITH AN ANTICHOLINERGIC BRONCHODILATATOR FOR THE TREATMENT OF ASTHMA OR CHRONIC OBSTRUCTIVE LUNG DISEASE | |
| WO2008048560A3 (en) | Toll-like receptor agonist regulation of vegf-induced tissue responses | |
| ZA200801407B (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma | |
| ZA200801408B (en) | A combination of compounds, which can be used in the treatment of respiratory diseases, especially chronic obstructive pulmonary disease (COPD) and asthma |